NORTHWEST BIOTHERAPEUTICS INC (NWBO) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
39/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseNWBO / S&P -9.52% / 15.20% |
WinNWBO / S&P 98.63% / 15.00% |
LoseNWBO / S&P -50.00% / 50.40% |
| 2026-Q10/3 |
LoseNWBO / S&P -8.70% / -4.33% |
LoseNWBO / S&P 1.63% / 11.30% |
LoseNWBO / S&P -57.14% / 27.70% |
| 2025-Q40/3 |
LoseNWBO / S&P -4.17% / 2.65% |
LoseNWBO / S&P -0.29% / 9.00% |
LoseNWBO / S&P -50.00% / 13.40% |
| 2025-Q30/3 |
LoseNWBO / S&P 0.00% / 8.12% |
LoseNWBO / S&P -41.29% / 4.61% |
LoseNWBO / S&P -14.29% / 13.45% |
| 2025-Q20/3 |
LoseNWBO / S&P 4.35% / 10.94% |
LoseNWBO / S&P -33.50% / 4.83% |
LoseNWBO / S&P -14.29% / 10.63% |
| 2025-Q12/3 |
LoseNWBO / S&P -14.81% / -4.27% |
WinNWBO / S&P 10.25% / 4.98% |
WinNWBO / S&P 16.67% / 10.57% |
| 2024-Q41/3 |
LoseNWBO / S&P -15.63% / 2.41% |
LoseNWBO / S&P -28.47% / 5.25% |
WinNWBO / S&P 60.00% / 6.15% |
| 2024-Q31/3 |
LoseNWBO / S&P -25.58% / 5.89% |
LoseNWBO / S&P -23.42% / 5.89% |
WinNWBO / S&P 16.67% / 6.11% |
| 2024-Q20/3 |
LoseNWBO / S&P -17.31% / 4.28% |
LoseNWBO / S&P -12.69% / 5.38% |
LoseNWBO / S&P -0.00% / 5.12% |
| 2024-Q10/3 |
LoseNWBO / S&P -25.71% / 10.56% |
LoseNWBO / S&P -38.15% / 5.71% |
LoseNWBO / S&P -14.29% / 5.59% |
| 2023-Q41/3 |
LoseNWBO / S&P -23.08% / 11.69% |
WinNWBO / S&P 14.80% / 6.81% |
LoseNWBO / S&P -28.57% / 7.78% |
| 2023-Q32/3 |
WinNWBO / S&P 59.65% / -3.27% |
WinNWBO / S&P 91.90% / 7.52% |
LoseNWBO / S&P -14.29% / -5.03% |
| 2023-Q22/3 |
LoseNWBO / S&P -9.52% / 8.74% |
WinNWBO / S&P 53.17% / 9.50% |
WinNWBO / S&P 40.00% / -8.57% |
| 2023-Q12/3 |
LoseNWBO / S&P -19.23% / 7.50% |
WinNWBO / S&P 84.77% / 10.77% |
WinNWBO / S&P 40.00% / -15.69% |
| 2022-Q43/3 |
WinNWBO / S&P 9.86% / 7.56% |
WinNWBO / S&P 67.46% / 11.88% |
WinNWBO / S&P 75.00% / -17.99% |
| 2022-Q31/3 |
WinNWBO / S&P 12.70% / -4.88% |
LoseNWBO / S&P -27.98% / 13.47% |
LoseNWBO / S&P -82.05% / -1.41% |
| 2022-Q21/3 |
WinNWBO / S&P -10.00% / -16.10% |
LoseNWBO / S&P -10.48% / 13.71% |
LoseNWBO / S&P -92.19% / 11.04% |
| 2022-Q12/3 |
WinNWBO / S&P 0.00% / -4.60% |
WinNWBO / S&P 21.77% / 15.97% |
LoseNWBO / S&P -92.96% / 42.23% |
| 2021-Q40/3 |
LoseNWBO / S&P -45.31% / 11.03% |
LoseNWBO / S&P -22.15% / 15.00% |
LoseNWBO / S&P -94.37% / 96.40% |
| 2021-Q30/3 |
LoseNWBO / S&P -12.93% / 0.58% |
LoseNWBO / S&P -10.50% / 10.77% |
LoseNWBO / S&P 18.18% / 69.42% |
| 2021-Q21/3 |
LoseNWBO / S&P -1.34% / 8.55% |
LoseNWBO / S&P -33.37% / 6.58% |
WinNWBO / S&P 700.00% / 51.81% |
| 2021-Q10/3 |
LoseNWBO / S&P -2.61% / 6.17% |
LoseNWBO / S&P -63.65% / -1.06% |
LoseNWBO / S&P -40928713413543067648.00% / 7.39% |
| 2020-Q42/3 |
WinNWBO / S&P 98.70% / 12.15% |
LoseNWBO / S&P -46.43% / -3.72% |
WinNWBO / S&P 1675.00% / -33.42% |
| 2020-Q32/3 |
WinNWBO / S&P 126.47% / 8.93% |
WinNWBO / S&P 58.66% / -2.04% |
LoseNWBO / S&P NWBO unavailable / -27.10% |
| 2020-Q22/3 |
WinNWBO / S&P 112.50% / 20.54% |
WinNWBO / S&P 123.64% / -0.46% |
LoseNWBO / S&P NWBO unavailable / -27.11% |
| 2020-Q11/3 |
LoseNWBO / S&P -23.81% / -19.60% |
WinNWBO / S&P 326.66% / 3.47% |
LoseNWBO / S&P NWBO unavailable / -14.75% |
| 2019-Q41/3 |
LoseNWBO / S&P -16.00% / 9.07% |
WinNWBO / S&P 484.95% / 5.36% |
LoseNWBO / S&P NWBO unavailable / 2.99% |
| 2019-Q31/3 |
LoseNWBO / S&P -3.85% / 1.70% |
WinNWBO / S&P 18.66% / 5.02% |
LoseNWBO / S&P NWBO unavailable / 0.21% |
| 2019-Q21/3 |
LoseNWBO / S&P -3.70% / 4.30% |
WinNWBO / S&P 56.27% / 6.64% |
LoseNWBO / S&P NWBO unavailable / 8.65% |
| 2019-Q12/3 |
WinNWBO / S&P 28.57% / 13.65% |
WinNWBO / S&P 54.75% / 8.12% |
LoseNWBO / S&P NWBO unavailable / 14.29% |
| 2018-Q42/3 |
WinNWBO / S&P 10.53% / -13.52% |
WinNWBO / S&P 22.62% / 9.05% |
LoseNWBO / S&P NWBO unavailable / 18.23% |
| 2018-Q31/3 |
LoseNWBO / S&P -26.92% / 7.71% |
WinNWBO / S&P 138.67% / 10.21% |
LoseNWBO / S&P NWBO unavailable / 19.06% |
| 2018-Q21/3 |
LoseNWBO / S&P -3.70% / 3.43% |
WinNWBO / S&P 52.85% / 9.03% |
LoseNWBO / S&P NWBO unavailable / 14.46% |
| 2018-Q11/3 |
WinNWBO / S&P 12.50% / -0.76% |
LoseNWBO / S&P -12.09% / 7.68% |
LoseNWBO / S&P NWBO unavailable / 12.46% |
| 2017-Q41/3 |
WinNWBO / S&P 33.33% / 6.64% |
LoseNWBO / S&P -46.07% / 7.03% |
LoseNWBO / S&P NWBO unavailable / 13.82% |
| 2017-Q31/3 |
WinNWBO / S&P 12.50% / 4.48% |
LoseNWBO / S&P -73.50% / 5.68% |
LoseNWBO / S&P NWBO unavailable / 17.57% |
| 2017-Q20/3 |
LoseNWBO / S&P -36.00% / 3.09% |
LoseNWBO / S&P -75.05% / 4.83% |
LoseNWBO / S&P NWBO unavailable / 17.74% |
| 2017-Q10/3 |
LoseNWBO / S&P -28.57% / 6.07% |
LoseNWBO / S&P -74.45% / 3.67% |
LoseNWBO / S&P NWBO unavailable / 13.32% |
| 2016-Q40/3 |
LoseNWBO / S&P -35.19% / 3.82% |
LoseNWBO / S&P -64.17% / 2.09% |
LoseNWBO / S&P NWBO unavailable / 7.05% |
| 2016-Q30/3 |
LoseNWBO / S&P -6.90% / 3.85% |
LoseNWBO / S&P -19.05% / 0.20% |
LoseNWBO / S&P NWBO unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | NWBO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -40.00% | 20.78% |
| Annualized return | -40.00% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | NWBO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -85.94% | 83.14% |
| Annualized return | -32.45% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | NWBO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -47.06% | 319.30% |
| Annualized return | -6.16% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.